Hiroaki Sakurai

Keyphrases

1. Activator protein-1 (AP-1) 23%
2. Antitumor Activity 12%
3. Apoptosis 18%
4. Breast Cancer Cells 14%
5. C-Jun N-terminal Kinase 14%
6. Cancer Cells 32%
7. Colon 26 14%
8. DNA Binding 11%
9. Endocytosis 15%
10. Epidermal Growth Factor Receptor 50%
11. Epidermal Growth Factor Receptor Signaling 11%
12. Extracellular Signal-regulated Kinase 17%
13. Gastric Cancer 11%
14. Glomerulonephritis 12%
15. HeLa Cells 15%
16. Human T-cell Leukemia Virus Type 1 (HTLV-1) 11%
17. In Cancer 18%
18. Induced Activation 16%
19. Induced Apoptosis 29%
20. Inhibitory Effect 17%
21. Interleukin-1β 13%
22. Juzentaihoto 11%
23. Kampo Medicine 13%
24. Lymphatic Endothelial Cells 19%
25. Melanoma 15%
26. Melanoma Cells 11%
27. Metastasis 25%
28. Mitogen-activated Protein Kinase 26%
29. NF-B 84%
30. Non-canonical 25%
31. Non-small Cell Lung Cancer (NSCLC) 12%
32. Nuclear factor-B 38%
33. P38 Mitogen-activated Protein Kinase (p38 MAPK) 15%
34. Phosphorylation 85%
35. Plasma Proteins 12%
36. Protein Kinase 15%
37. Receptor Tyrosine Kinase 12%
38. Signaling Pathway 34%
39. TAB2 12%
40. TAK1 100%
41. TAK1-Binding Proteins 18%
42. TRAIL-induced Apoptosis 17%
43. Transcription Factor 16%
44. Transforming Growth Factor-β 29%
45. Tumor Cells 12%
46. Tumor Growth 13%
47. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) 14%
48. Tumor Necrosis Factor-α 57%
49. Tyrosine Phosphorylation 11%
50. Ubc13 11%